A new study provides the strongest support yet for abnormal α-synuclein as a diagnostic biomarker that shows up even in the prodromal phase — with immediate implications for trial design and therapeutic development.

中文翻译：

---

生物标志物研究改变帕金森病的游戏规则

一项新研究为异常 α-突触核蛋白作为一种诊断生物标志物提供了迄今为止最有力的支持，它甚至在前驱期就出现了——对试验设计和治疗开发有直接影响。